Atlas Trials

A Clinical Study on Immunogenicity Persistence of Adsorbed 5-component Acellular Pertussis, Diphtheria and Tetanus Combined Vaccine

Clinical trial NCT07744347 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07744347
Sponsor
CanSino Biologics Inc.
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
DiphtheriaTetanusPertussis
Start date
2026-10-15
Primary completion
2033-10-15
Enrollment
160

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.